# Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis

> **NCT05944627** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Kang Stem Biotech Co., Ltd.** · enrollment: 68 (estimated)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **BIOLOGICAL:** FURESTEM-OA Kit Inj.
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT05944627
- **Lead sponsor:** Kang Stem Biotech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-06
- **Primary completion:** 2024-03-31
- **Final completion:** 2026-02-28
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2023-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05944627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05944627, "Evaluate Safety and Explore Efficacy of FURESTEM-OA Kit Inj. in Patients With Knee Osteoarthritis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05944627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*